{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:11:55Z","timestamp":1780636315133,"version":"3.54.1"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"DOI":"10.1007\/s11920-025-01644-2","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:16:34Z","timestamp":1759918594000},"page":"782-794","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Psychiatric Considerations in Breast Cancer: an Integrative Review"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1521-7002","authenticated-orcid":false,"given":"Lindsay G.","family":"Lebin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine C.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Pointer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Baurle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"1644_CR1","doi-asserted-by":"crossref","unstructured":"1. Waks AG, Winer EP. Breast Cancer Treatment: A Review. Jama. 2019;321(3):288\u2013300. doi: 10.1001\/jama.2018.19323.","DOI":"10.1001\/jama.2018.19323"},{"key":"1644_CR2","doi-asserted-by":"crossref","unstructured":"2. Nardin S, Mora E, Varughese FM, D\u2019Avanzo F, Vachanaram AR, Rossi V, et al. Breast Cancer Survivorship, Quality of Life, and Late Toxicities. Front Oncol. 2020;10:864. doi: 10.3389\/fonc.2020.00864.","DOI":"10.3389\/fonc.2020.00864"},{"key":"1644_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djae287","author":"M Aboumrad","year":"2024","unstructured":"Aboumrad M, Joshu C, Visvanathan K. Impact of major depressive disorder on breast cancer outcomes: a national retrospective cohort study. J Natl Cancer Inst. 2024. https:\/\/doi.org\/10.1093\/jnci\/djae287.","journal-title":"J Natl Cancer Inst"},{"key":"1644_CR4","doi-asserted-by":"crossref","unstructured":"4. Hegel MT, Moore CP, Collins ED, Kearing S, Gillock KL, Riggs RL, et al. Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer. Cancer. 2006;107(12):2924-31. doi: 10.1002\/cncr.22335.","DOI":"10.1002\/cncr.22335"},{"key":"1644_CR5","doi-asserted-by":"crossref","unstructured":"5. Tang H-y, Xiong H-h, Deng L-c, Fang Y-x, Zhang J, Meng H. Adjustment Disorder in Female Breast Cancer Patients: Prevalence and Its Accessory Symptoms. Current Medical Science. 2020;40(3):510-7. doi: 10.1007\/s11596-020-2205-1.","DOI":"10.1007\/s11596-020-2205-1"},{"issue":"4","key":"1644_CR6","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1007\/s00520-022-06806-z","volume":"30","author":"LMA Wijnhoven","year":"2022","unstructured":"Wijnhoven LMA, Custers JAE, Kwakkenbos L, Prins JB. Trajectories of adjustment disorder symptoms in post-treatment breast cancer survivors. Support Care Cancer. 2022;30(4):3521\u201330. https:\/\/doi.org\/10.1007\/s00520-022-06806-z.","journal-title":"Support Care Cancer"},{"key":"1644_CR7","doi-asserted-by":"crossref","unstructured":"7. Hashemi SM, Rafiemanesh H, Aghamohammadi T, Badakhsh M, Amirshahi M, Sari M, et al. Prevalence of anxiety among breast cancer patients: a systematic review and meta-analysis. Breast Cancer. 2020;27(2):166\u2009\u2212\u200978. doi: 10.1007\/s12282-019-01031-9.","DOI":"10.1007\/s12282-019-01031-9"},{"key":"1644_CR8","doi-asserted-by":"crossref","unstructured":"8. Fortin J, Leblanc M, Elgbeili G, Cordova MJ, Marin MF, Brunet A. The mental health impacts of receiving a breast cancer diagnosis: A meta-analysis. Br J Cancer. 2021;125(11):1582-92. doi: 10.1038\/s41416-021-01542-3.","DOI":"10.1038\/s41416-021-01542-3"},{"key":"1644_CR9","doi-asserted-by":"crossref","unstructured":"9. Arnaboldi P, Riva S, Crico C, Pravettoni G. A systematic literature review exploring the prevalence of post-traumatic stress disorder and the role played by stress and traumatic stress in breast cancer diagnosis and trajectory. Breast Cancer (Dove Med Press). 2017;9:473\u2009\u2212\u200985. doi: 10.2147\/bctt.S111101.","DOI":"10.2147\/BCTT.S111101"},{"key":"1644_CR10","doi-asserted-by":"crossref","unstructured":"10. Janelsins MC, Kesler SR, Ahles TA, Morrow GR. Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry. 2014;26(1):102\u2009\u2212\u200913. doi: 10.3109\/09540261.2013.864260.","DOI":"10.3109\/09540261.2013.864260"},{"key":"1644_CR11","doi-asserted-by":"crossref","unstructured":"11. Wagner LI, Gray RJ, Sparano JA, Whelan TJ, Garcia SF, Yanez B, et al. Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx. J Clin Oncol. 2020;38(17):1875-86. doi: 10.1200\/jco.19.01866.","DOI":"10.1200\/JCO.19.01866"},{"key":"1644_CR12","doi-asserted-by":"crossref","unstructured":"12. \u0130zci F, \u0130lg\u00fcn AS, F\u0131nd\u0131kl\u0131 E, \u00d6zmen V. Psychiatric Symptoms and Psychosocial Problems in Patients with Breast Cancer. J Breast Health. 2016;12(3):94\u2013101. doi: 10.5152\/tjbh.2016.3041.","DOI":"10.5152\/tjbh.2016.3041"},{"key":"1644_CR13","doi-asserted-by":"crossref","unstructured":"13. Tang W-Z, Mangantig E, Iskandar YHP, Cheng S-l, Yusuf A, Jia K. Prevalence and associated factors of psychological distress among patients with breast cancer: a systematic review and meta-analysis. BMJ Open. 2024;14(9):e077067. doi: 10.1136\/bmjopen-2023-077067.","DOI":"10.1136\/bmjopen-2023-077067"},{"key":"1644_CR14","doi-asserted-by":"crossref","unstructured":"14. Lazenby M, Ercolano E, Grant M, Holland JC, Jacobsen PB, McCorkle R. Supporting commission on cancer-mandated psychosocial distress screening with implementation strategies. J Oncol Pract. 2015;11(3):e413-20. doi: 10.1200\/jop.2014.002816.","DOI":"10.1200\/JOP.2014.002816"},{"key":"1644_CR15","doi-asserted-by":"crossref","unstructured":"15. Civilotti C, Acquadro Maran D, Santagata F, Varetto A, Stanizzo MR. The use of the Distress Thermometer and the Hospital Anxiety and Depression Scale for screening of anxiety and depression in Italian women newly diagnosed with breast cancer. Support Care Cancer. 2020;28(10):4997\u20135004. doi: 10.1007\/s00520-020-05343-x.","DOI":"10.1007\/s00520-020-05343-x"},{"key":"1644_CR16","unstructured":"16. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines \u00ae) Distress Management Version 3.2019 \u2014 May 6, 2019. https:\/\/www.accc-cancer.org\/docs\/projects\/psychosocial-distress-screening\/nccn-distress_5-6-2019.pdf?sfvrsn=882ba01_2& (2019). Accessed April 27 2025."},{"key":"1644_CR17","doi-asserted-by":"crossref","unstructured":"17. R K, L S, P B, S G, R L-P. Psychosocial experiences of breast cancer survivors: a meta-review. J Cancer Surviv. 2024;18(1):84\u2013123. doi: 10.1007\/s11764-023-01336-x.","DOI":"10.1007\/s11764-023-01336-x"},{"key":"1644_CR18","doi-asserted-by":"crossref","unstructured":"18. Dinapoli L, Colloca G, Di Capua B, Valentini V. Psychological Aspects to Consider in Breast Cancer Diagnosis and Treatment. Curr Oncol Rep. 2021;23(3):38. doi: 10.1007\/s11912-021-01049-3.","DOI":"10.1007\/s11912-021-01049-3"},{"key":"1644_CR19","doi-asserted-by":"crossref","unstructured":"19. Cernikova KA, Kracmarova LK, Pesoutova M, Tavel P. We will be different forever: A qualitative study of changes of body image in women with breast cancer. BMC Public Health. 2024;24(1):2517. doi: 10.1186\/s12889-024-20017-7.","DOI":"10.1186\/s12889-024-20017-7"},{"key":"1644_CR20","doi-asserted-by":"crossref","unstructured":"20. Di Mattei VE, Perego G, Taranto P, Mazzetti M, Ferrari F, Derna N, et al. Psychological issues in breast cancer survivors confronted with motherhood: Literature review and a call to action. Front Psychol. 2023;14:1133204. doi: 10.3389\/fpsyg.2023.1133204.","DOI":"10.3389\/fpsyg.2023.1133204"},{"key":"1644_CR21","doi-asserted-by":"crossref","unstructured":"21. Naik H, Leung B, Laskin J, McDonald M, Srikanthan A, Wu J, et al. Emotional distress and psychosocial needs in patients with breast cancer in British Columbia: younger versus older adults. Breast Cancer Res Treat. 2020;179(2):471-7. doi: 10.1007\/s10549-019-05468-6.","DOI":"10.1007\/s10549-019-05468-6"},{"key":"1644_CR22","doi-asserted-by":"crossref","unstructured":"22. Abboah-Offei M, Bayuo J, Salifu Y, Afolabi O, Akudjedu TN. Experiences and perceptions of men following breast cancer diagnosis: a mixed method systematic review. BMC Cancer. 2024;24(1):179. doi: 10.1186\/s12885-024-11911-9.","DOI":"10.1186\/s12885-024-11911-9"},{"key":"1644_CR23","doi-asserted-by":"crossref","unstructured":"23. Rivers AS, Sanford K. A special kind of stress: Assessing feelings of decisional distress for breast cancer treatment decisions. Patient Education and Counseling. 2021;104(12):3038-44. doi: 10.1016\/j.pec.2021.04.020.","DOI":"10.1016\/j.pec.2021.04.020"},{"key":"1644_CR24","doi-asserted-by":"crossref","unstructured":"24. Shekhar N, Jaiswal R, Joseph L, Jain S, Jain S, Kr A, et al. An Overview of Psychological Analysis of Breast Cancer Patients undergoing Modified Radical Mastectomy and Breast Conservation Surgery and its impact on Objectified Body Consciousness at a Tertiary Care Cancer Centre in South India. Clin Breast Cancer. 2023;23(7):e394-e400. doi: 10.1016\/j.clbc.2023.05.017.","DOI":"10.1016\/j.clbc.2023.05.017"},{"key":"1644_CR25","doi-asserted-by":"crossref","unstructured":"25. Hanson SE, Lei X, Roubaud MS, DeSnyder SM, Caudle AS, Shaitelman SF, et al. Long-term Quality of Life in Patients With Breast Cancer After Breast Conservation vs Mastectomy and Reconstruction. JAMA Surgery. 2022;157(6):e220631-e. doi: 10.1001\/jamasurg.2022.0631.","DOI":"10.1001\/jamasurg.2022.0631"},{"key":"1644_CR26","doi-asserted-by":"crossref","unstructured":"26. Stern CS, Kim M, Smith Montes E, Boe LA, Zhang K, Vingan P, et al. Breast-Conserving Therapy Preserves Sexual Well-Being More than Postmastectomy Breast Reconstruction: Trends, Factors, and Interventions. Plastic and Reconstructive Surgery. 2025;155(3):407\u2009\u2212\u200920. doi: 10.1097\/prs.0000000000011657.","DOI":"10.1097\/PRS.0000000000011657"},{"key":"1644_CR27","doi-asserted-by":"crossref","unstructured":"27. Song Y, Wang L, Huang W, Guo S, Wu X, Zheng H. Comparison of nipple sparing and skin sparing mastectomy with immediate reconstruction based on patient reported outcomes. Scientific Reports. 2025;15(1):14989. doi: 10.1038\/s41598-025-99834-8.","DOI":"10.1038\/s41598-025-99834-8"},{"key":"1644_CR28","doi-asserted-by":"crossref","unstructured":"28. Clarijs ME, Peeters NJMCV, van Dongen SAF, Koppert LB, Pusic AL, Mureau MAM, et al. Quality of Life and Complications after Nipple- versus Skin-Sparing Mastectomy followed by Immediate Breast Reconstruction: A Systematic Review and Meta-Analysis. Plastic and Reconstructive Surgery. 2023;152(1):12e-24e. doi: 10.1097\/prs.0000000000010155.","DOI":"10.1097\/PRS.0000000000010155"},{"key":"1644_CR29","doi-asserted-by":"crossref","unstructured":"29. Hwang ES, Locklear TD, Rushing CN, Samsa G, Abernethy AP, Hyslop T, et al. Patient-Reported Outcomes After Choice for Contralateral Prophylactic Mastectomy. J Clin Oncol. 2016;34(13):1518-27. doi: 10.1200\/jco.2015.61.5427.","DOI":"10.1200\/JCO.2015.61.5427"},{"key":"1644_CR30","doi-asserted-by":"crossref","unstructured":"30. Parker PA, Peterson SK, Shen Y, Bedrosian I, Black DM, Thompson AM, et al. Prospective Study of Psychosocial Outcomes of Having Contralateral Prophylactic Mastectomy Among Women With Nonhereditary Breast Cancer. J Clin Oncol. 2018;36(25):2630-8. doi: 10.1200\/jco.2018.78.6442.","DOI":"10.1200\/JCO.2018.78.6442"},{"key":"1644_CR31","doi-asserted-by":"crossref","unstructured":"31. Arthur EK, Ridgway-Limle EA, Krok-Schoen JL, Boehmer U, Battle-Fisher M, Lee CN. Scoping review of experiences of sexual minority women treated for breast cancer. J Psychosoc Oncol. 2024;42(5):709\u2009\u2212\u200932. doi: 10.1080\/07347332.2024.2323471.","DOI":"10.1080\/07347332.2024.2323471"},{"key":"1644_CR32","doi-asserted-by":"crossref","unstructured":"32. Almeida V, Pires D, Silva M, Teixeira M, Teixeira RJ, Louro A, et al. Dermatological Side Effects of Cancer Treatment: Psychosocial Implications-A Systematic Review of the Literature. Healthcare (Basel). 2023;11(19). doi: 10.3390\/healthcare11192621.","DOI":"10.3390\/healthcare11192621"},{"issue":"24","key":"1644_CR33","doi-asserted-by":"publisher","first-page":"4636","DOI":"10.1200\/jco.2002.05.088","volume":"33","author":"XL Du","year":"2002","unstructured":"Du XL, Osborne C, Goodwin JS. Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer. J Clin Oncol. 2002;33(24):4636\u201342. https:\/\/doi.org\/10.1200\/jco.2002.05.088.","journal-title":"J Clin Oncol"},{"key":"1644_CR34","doi-asserted-by":"crossref","unstructured":"34. Brahmer JR, Lacchetti C, Schneider BJ, Atkins MB, Brassil KJ, Caterino JM, et al. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2018;36(17):1714-68. doi: 10.1200\/jco.2017.77.6385.","DOI":"10.1200\/JCO.2017.77.6385"},{"key":"1644_CR35","doi-asserted-by":"crossref","unstructured":"35. Piroth MD, Draia S, Jawad JA, Piefke M. Anxiety and depression in patients with breast cancer undergoing radiotherapy: the role of intelligence, life history, and social support-preliminary results from a monocentric analysis. Strahlenther Onkol. 2022;198(4):388\u2009\u2212\u200996. doi: 10.1007\/s00066-022-01904-7.","DOI":"10.1007\/s00066-022-01904-7"},{"key":"1644_CR36","doi-asserted-by":"crossref","unstructured":"36. Elamin N, Althebity N, Alkhamisi TA, Al-Foheidi M. Sleep quality and psychological disorders in breast cancer female patients receiving radiotherapy at a tertiary oncology center in West Saudi Arabia. Support Care Cancer. 2024;32(3):163. doi: 10.1007\/s00520-024-08368-8.","DOI":"10.1007\/s00520-024-08368-8"},{"key":"1644_CR37","doi-asserted-by":"crossref","unstructured":"37. Cucciniello L, Garufi G, Di Rienzo R, Martinelli C, Pavone G, Giuliano M, et al. Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome. Cancer Treat Rev. 2023;120:102624. doi: 10.1016\/j.ctrv.2023.102624.","DOI":"10.1016\/j.ctrv.2023.102624"},{"key":"1644_CR38","doi-asserted-by":"crossref","unstructured":"38. Ilhan RG, Ilhan Y, Goksu SS, Tatli AM, Coskun HS. The effect of using adjuvant aromatase inhibitors on cognitive functions in postmenopausal women with hormone receptor-positive breast cancer. Journal of Cancer Research and Therapeutics. 2023;19(Suppl 1).","DOI":"10.4103\/jcrt.jcrt_632_21"},{"key":"1644_CR39","doi-asserted-by":"crossref","unstructured":"39. Bender CM, Merriman JD, Gentry AL, Ahrendt GM, Berga SL, Brufsky AM, et al. Patterns of change in cognitive function with anastrozole therapy. Cancer. 2015;121(15):2627-36. doi: 10.1002\/cncr.29393.","DOI":"10.1002\/cncr.29393"},{"key":"1644_CR40","doi-asserted-by":"crossref","unstructured":"40. Novick AM, Scott AT, Neill Epperson C, Schneck CD. Neuropsychiatric effects of tamoxifen: Challenges and opportunities. Front Neuroendocrinol. 2020;59:100869. doi: 10.1016\/j.yfrne.2020.100869.","DOI":"10.1016\/j.yfrne.2020.100869"},{"key":"1644_CR41","doi-asserted-by":"crossref","unstructured":"41. Jebahi F, Sharma S, Bloss JE, Wright HH. Effects of tamoxifen on cognition and language in women with breast cancer: A systematic search and a scoping review. Psychooncology. 2021;30(8):1262-77. doi: 10.1002\/pon.5696.","DOI":"10.1002\/pon.5696"},{"key":"1644_CR42","doi-asserted-by":"crossref","unstructured":"42. Garc\u00eda-S\u00e1nchez J, Mafla-Espa\u00f1a MA, Torregrosa MD, Cauli O. Adjuvant aromatase inhibitor treatment worsens depressive symptoms and sleep quality in postmenopausal women with localized breast cancer: A one-year follow-up study. Breast. 2022;66:310-6. doi: 10.1016\/j.breast.2022.11.007.","DOI":"10.1016\/j.breast.2022.11.007"},{"key":"1644_CR43","doi-asserted-by":"crossref","unstructured":"43. Martino G, Catalano A, Agostino RM, Bellone F, Morabito N, Lasco CG, et al. Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer. PLoS One. 2020;15(3):e0230681. doi: 10.1371\/journal.pone.0230681.","DOI":"10.1371\/journal.pone.0230681"},{"key":"1644_CR44","doi-asserted-by":"crossref","unstructured":"44. Carmassi C, Cordone A, Dell\u2019Oste V, Pedrinelli V, Pardini F, Simoncini M, et al. Prescribing Tamoxifen in Patients With Mood Disorders: A Systematic Review of Potential Antimanic Versus Depressive Effects. J Clin Psychopharmacol. 2021;41(4):450\u2009\u2212\u200960. doi: 10.1097\/jcp.0000000000001412.","DOI":"10.1097\/JCP.0000000000001412"},{"key":"1644_CR45","doi-asserted-by":"crossref","unstructured":"45. Tong L, Wang Y, Xu D, Wu Y, Chen L. Prevalence and Factors Contributing to Fear of Recurrence in Breast Cancer Patients and Their Partners: A Cross-Sectional Study. Int J Womens Health. 2024;16:229\u2009\u2212\u200936. doi: 10.2147\/ijwh.S443681.","DOI":"10.2147\/IJWH.S443681"},{"key":"1644_CR46","doi-asserted-by":"crossref","unstructured":"46. Schapira L, Zheng Y, Gelber SI, Poorvu P, Ruddy KJ, Tamimi RM, et al. Trajectories of fear of cancer recurrence in young breast cancer survivors. Cancer. 2022;128(2):335\u2009\u2212\u200943. doi: 10.1002\/cncr.33921.","DOI":"10.1002\/cncr.33921"},{"key":"1644_CR47","doi-asserted-by":"crossref","unstructured":"47. Hall DL, Wagner LI, Lebel S, Smith AB, Bergerot CD, Park ER. Guidelines needed for the management of fear of cancer recurrence in adult survivors of cancer in the United States: A consensus statement. Cancer. 2024;130(16):2739-42. doi: 10.1002\/cncr.35326.","DOI":"10.1002\/cncr.35326"},{"key":"1644_CR48","doi-asserted-by":"crossref","unstructured":"48. Matbouei M, Samsami M, Soleimani M. Breast Cancer Survivors\u2019 Experiences of Acceptance Following Recurrence: A Qualitative Content Analysis. Cancer Nurs. 2024;47(4):E226-e35. doi: 10.1097\/ncc.0000000000001217.","DOI":"10.1097\/NCC.0000000000001217"},{"key":"1644_CR49","doi-asserted-by":"crossref","unstructured":"49. Ghislain I, Zikos E, Coens C, Quinten C, Balta V, Tryfonidis K, et al. Health-related quality of life in locally advanced and metastatic breast cancer: methodological and clinical issues in randomised controlled trials. Lancet Oncol. 2016;17(7):e294-e304. doi: 10.1016\/s1470-2045(16)30099-7.","DOI":"10.1016\/S1470-2045(16)30099-7"},{"key":"1644_CR50","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.genhosppsych.2025.02.023","volume":"94","author":"R Philipp","year":"2025","unstructured":"Philipp R, Walbaum C, Koch U, Oechsle K, Daniels T, Helmich F, et al. Existential distress in advanced cancer: a cohort study. Gen Hosp Psychiatry. 2025;94:184\u201391. https:\/\/doi.org\/10.1016\/j.genhosppsych.2025.02.023.","journal-title":"Gen Hosp Psychiatry"},{"key":"1644_CR51","doi-asserted-by":"crossref","unstructured":"51. Melton L, Krause D, Sugalski J. Psychology Staffing at Cancer Centers: Data From National Comprehensive Cancer Network Member Institutions. JCO Oncol Pract. 2020;16(11):e1343-e54. doi: 10.1200\/op.20.00087.","DOI":"10.1200\/OP.20.00087"},{"key":"1644_CR52","doi-asserted-by":"crossref","unstructured":"52. Akechi T, Momino K, Katsuki F, Yamashita H, Sugiura H, Yoshimoto N, et al. Brief collaborative care intervention to reduce perceived unmet needs in highly distressed breast cancer patients: randomized controlled trial. Jpn J Clin Oncol. 2021;51(2):244\u2009\u2212\u200951. doi: 10.1093\/jjco\/hyaa166.","DOI":"10.1093\/jjco\/hyaa166"},{"key":"1644_CR53","doi-asserted-by":"crossref","unstructured":"53. Bidstrup PE, Johansen C, Kroman N, Belmonte F, Duriaud H, Dalton SO, et al. Effect of a Nurse Navigation Intervention on Mental Symptoms in Patients With Psychological Vulnerability and Breast Cancer: The REBECCA Randomized Clinical Trial. JAMA Netw Open. 2023;6(6):e2319591. doi: 10.1001\/jamanetworkopen.2023.19591.","DOI":"10.1001\/jamanetworkopen.2023.19591"},{"key":"1644_CR54","unstructured":"54. Health Behavior Assessment and Intervention Services. https:\/\/www.apaservices.org\/practice\/reimbursement\/health-codes\/health-behavior Accessed April 27 2025."},{"key":"1644_CR55","doi-asserted-by":"publisher","unstructured":"55. Johns KN, Kalister S, Mwandha N, Adams EJ, Basinger H, Fugett S, et al. Applying the Collaborative Care Model to treat depression and anxiety in breast cancer (BC) patients. Journal of Clinical Oncology. 2020;38. doi: https:\/\/doi.org\/10.1200\/JCO.2020.38.15_suppl.e1400.","DOI":"10.1200\/JCO.2020.38.15_suppl.e1400."},{"key":"1644_CR56","doi-asserted-by":"crossref","unstructured":"56. Doshi SD, Charvadeh YK, Seier K, Bange EM, Daly B, Lipitz-Snyderman A, et al. Perspectives on Telemedicine Visits Reported by Patients With Cancer. JAMA Netw Open. 2024;7(11):e2445363. doi: 10.1001\/jamanetworkopen.2024.45363.","DOI":"10.1001\/jamanetworkopen.2024.45363"},{"key":"1644_CR57","unstructured":"57. Telehealth Policy Updates. https:\/\/telehealth.hhs.gov\/providers\/telehealth-policy\/telehealth-policy-updates#behavioral-health Accessed August 23 2025."},{"key":"1644_CR58","doi-asserted-by":"crossref","unstructured":"58. Licht T, Nickels A, Rumpold G, Holzner B, Riedl D. Evaluation by electronic patient-reported outcomes of cancer survivors\u2019 needs and the efficacy of inpatient cancer rehabilitation in different tumor entities. Support Care Cancer. 2021;29(10):5853-64. doi: 10.1007\/s00520-021-06123-x.","DOI":"10.1007\/s00520-021-06123-x"},{"key":"1644_CR59","doi-asserted-by":"crossref","unstructured":"59. Singleton AC, Raeside R, Hyun KK, Partridge SR, Di Tanna GL, Hafiz N, et al. Electronic Health Interventions for Patients With Breast Cancer: Systematic Review and Meta-Analyses. J Clin Oncol. 2022;40(20):2257-70. doi: 10.1200\/jco.21.01171.","DOI":"10.1200\/JCO.21.01171"},{"key":"1644_CR60","doi-asserted-by":"crossref","unstructured":"60. Saevarsdottir SR, Gudmundsdottir SL. Mobile Apps and Quality of Life in Patients With Breast Cancer and Survivors: Systematic Literature Review. J Med Internet Res. 2023;25:e42852. doi: 10.2196\/42852.","DOI":"10.2196\/42852"},{"key":"1644_CR61","doi-asserted-by":"crossref","unstructured":"61. Peters L, Brederecke J, Franzke A, de Zwaan M, Zimmermann T. Psychological Distress in a Sample of Inpatients With Mixed Cancer-A Cross-Sectional Study of Routine Clinical Data. Front Psychol. 2020;11:591771. doi: 10.3389\/fpsyg.2020.591771.","DOI":"10.3389\/fpsyg.2020.591771"},{"key":"1644_CR62","doi-asserted-by":"crossref","unstructured":"62. Ford DM, Budworth L, Lawton R, Teale EA, O\u2019Connor DB. In-hospital stress and patient outcomes: A systematic review and meta-analysis. PLoS One. 2023;18(3):e0282789. doi: 10.1371\/journal.pone.0282789.","DOI":"10.1371\/journal.pone.0282789"},{"key":"1644_CR63","doi-asserted-by":"crossref","unstructured":"63. Bullock AJ, Sorbello A, Gilrain KL, Fizur P, Aplin KS. Patient Satisfaction with a Psychology Consultation-Liaison Service at an Academic Medical Center. J Clin Psychol Med Settings. 2022;29(4):717\u2009\u2212\u200926. doi: 10.1007\/s10880-021-09829-6.","DOI":"10.1007\/s10880-021-09829-6"},{"key":"1644_CR64","doi-asserted-by":"crossref","unstructured":"64. Cipolletta S, Simonato C, Faccio E. The Effectiveness of Psychoeducational Support Groups for Women With Breast Cancer and Their Caregivers: A Mixed Methods Study. Front Psychol. 2019;10:288. doi: 10.3389\/fpsyg.2019.00288.","DOI":"10.3389\/fpsyg.2019.00288"},{"key":"1644_CR65","doi-asserted-by":"crossref","unstructured":"65. McCaughan E, Parahoo K, Hueter I, Northouse L, Bradbury I. Online support groups for women with breast cancer. Cochrane Database Syst Rev. 2017;3(3):Cd011652. doi: 10.1002\/14651858.CD011652.pub2.","DOI":"10.1002\/14651858.CD011652.pub2"},{"key":"1644_CR66","doi-asserted-by":"crossref","unstructured":"66. Penberthy JK, Stewart AL, Centeno CF, Penberthy DR. Psychological Aspects of Breast Cancer. Psychiatr Clin North Am. 2023;46(3):551\u2009\u2212\u200970. doi: 10.1016\/j.psc.2023.04.010.","DOI":"10.1016\/j.psc.2023.04.010"},{"key":"1644_CR67","doi-asserted-by":"crossref","unstructured":"67. Breitbart W, Pessin H, Rosenfeld B, Applebaum AJ, Lichtenthal WG, Li Y, et al. Individual meaning-centered psychotherapy for the treatment of psychological and existential distress: A randomized controlled trial in patients with advanced cancer. Cancer. 2018;124(15):3231-9. doi: 10.1002\/cncr.31539.","DOI":"10.1002\/cncr.31539"},{"issue":"5","key":"1644_CR68","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.beth.2024.03.005","volume":"55","author":"JH Marco","year":"2024","unstructured":"Marco JH, Llombart P, Romero R, Garc\u00eda-Conde A, Corral V, Guillen V, et al. Meaning-centered psychotherapy versus cognitive behavioral therapy for cancer survivors: a randomized controlled trial\u2606. Behav Ther. 2024;55(5):1071\u201383. https:\/\/doi.org\/10.1016\/j.beth.2024.03.005.","journal-title":"Behav Ther"},{"key":"1644_CR69","doi-asserted-by":"crossref","unstructured":"69. Weiner LS, Nagel S, Irene Su H, Hurst S, Levy SS, Arredondo EM, et al. A remotely delivered, peer-led intervention to improve physical activity and quality of life in younger breast cancer survivors. J Behav Med. 2023;46(4):578\u2009\u2212\u200993. doi: 10.1007\/s10865-022-00381-8.","DOI":"10.1007\/s10865-022-00381-8"},{"key":"1644_CR70","doi-asserted-by":"crossref","unstructured":"70. Lewis-Smith H, Jones A, White P, Byford S, Fairbrother P, Potter S, et al. Accepting your Body after Cancer (ABC), a group-based online intervention for women treated for breast cancer: study protocol for a feasibility randomised controlled trial. BMJ Open. 2025;15(1):e097817. doi: 10.1136\/bmjopen-2024-097817.","DOI":"10.1136\/bmjopen-2024-097817"},{"key":"1644_CR71","doi-asserted-by":"crossref","unstructured":"71. L\u00f3pez-Contreras JP, Sebri V, Sarri\u00f3n-Castell\u00f3 P, Mart\u00ednez-Sanch\u00eds S, Cebolla IMAJ. Efficacy of Compassion-Based Interventions in Breast Cancer Patients and Survivors: A Systematic Review of Randomized Controlled Trials. Span J Psychol. 2024;27:e31. doi: 10.1017\/sjp.2024.31.","DOI":"10.1017\/SJP.2024.31"},{"key":"1644_CR72","doi-asserted-by":"crossref","unstructured":"72. Zhao W, Chong YY, Chien WT. Effectiveness of cognitive-based interventions for improving body image of patients having breast cancer: A systematic review and meta-analysis. Asia Pac J Oncol Nurs. 2023;10(4):100213. doi: 10.1016\/j.apjon.2023.100213.","DOI":"10.1016\/j.apjon.2023.100213"},{"key":"1644_CR73","doi-asserted-by":"crossref","unstructured":"73. Soleymani Moghadam M, Parvizifard A, Foroughi A, Ahmadi SM, Farshchian N. An investigation of the effect of mindfulness-integrated cognitive behavior therapy on demoralization, body image, and sexual function in Iranian women with breast cancer: a randomized controlled trial. J Cancer Res Clin Oncol. 2024;150(3):128. doi: 10.1007\/s00432-024-05655-z.","DOI":"10.1007\/s00432-024-05655-z"},{"key":"1644_CR74","doi-asserted-by":"crossref","unstructured":"74. Sebri V, Durosini I, Triberti S, Pravettoni G. The Efficacy of Psychological Intervention on Body Image in Breast Cancer Patients and Survivors: A Systematic-Review and Meta-Analysis. Front Psychol. 2021;12:611954. doi: 10.3389\/fpsyg.2021.611954.","DOI":"10.3389\/fpsyg.2021.611954"},{"key":"1644_CR75","doi-asserted-by":"crossref","unstructured":"75. Xu J, Xue B, Li L, Qiao J, Redding SR, Ouyang YQ. Psychological interventions for sexual function and satisfaction of women with breast cancer: A systematic review and meta-analysis. J Clin Nurs. 2023;32(9\u201310):2282-97. doi: 10.1111\/jocn.16194.","DOI":"10.1111\/jocn.16194"},{"key":"1644_CR76","doi-asserted-by":"crossref","unstructured":"76. Teo I, Tan YP, Goh A, Pan FT, Tan TJ, Ozdemir S, et al. The Renewing Intimacy and SExuality Intervention for Female Cancer Survivors: A Feasibility Study. Psychooncology. 2024;33(12):e70037. doi: 10.1002\/pon.70037.","DOI":"10.1002\/pon.70037"},{"key":"1644_CR77","doi-asserted-by":"crossref","unstructured":"77. Li M, Zhang L, Li N, Luo X, Chen J, Zhang Y, et al. Effects of couple-based dyadic interventions on breast cancer patients and their intimate partners: A systematic review and meta-analysis. J Adv Nurs. 2023;79(9):3192\u2009\u2212\u2009213. doi: 10.1111\/jan.15639.","DOI":"10.1111\/jan.15639"},{"key":"1644_CR78","doi-asserted-by":"crossref","unstructured":"78. Hiltrop K, Heidkamp P, Breidenbach C, Kowalski C, Streibelt M, Ernstmann N. Conflicting demands, coping, and adjustment: A grounded theory to understand rehabilitation processes in long-term breast cancer survivors. Psychooncology. 2021;30(11):1957-64. doi: 10.1002\/pon.5769.","DOI":"10.1002\/pon.5769"},{"key":"1644_CR79","doi-asserted-by":"crossref","unstructured":"79. Pezzella G, Moslinger-Gehmayr R, Contu A. Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline. Breast Cancer Res Treat. 2001;70(1):1\u201310. doi: 10.1023\/a:1012518831494.","DOI":"10.1023\/A:1012518831494"},{"key":"1644_CR80","doi-asserted-by":"crossref","unstructured":"80. Navari RM, Brenner MC, Wilson MN. Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy. Breast Cancer Res Treat. 2008;112(1):197\u2013201. doi: 10.1007\/s10549-007-9841-z.","DOI":"10.1007\/s10549-007-9841-z"},{"key":"1644_CR81","doi-asserted-by":"crossref","unstructured":"81. Musselman DL, Somerset WI, Guo Y, Manatunga AK, Porter M, Penna S, et al. A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression. J Clin Psychiatry. 2006;67(2):288\u2009\u2212\u200996. doi: 10.4088\/jcp.v67n0217.","DOI":"10.4088\/JCP.v67n0217"},{"key":"1644_CR82","doi-asserted-by":"crossref","unstructured":"82. van Heeringen K, Zivkov M. Pharmacological treatment of depression in cancer patients. A placebo-controlled study of mianserin. Br J Psychiatry. 1996;169(4):440-3. doi: 10.1192\/bjp.169.4.440.","DOI":"10.1192\/bjp.169.4.440"},{"key":"1644_CR83","doi-asserted-by":"crossref","unstructured":"83. Grassi L, Biancosino B, Marmai L, Righi R. Effect of reboxetine on major depressive disorder in breast cancer patients: an open-label study. J Clin Psychiatry. 2004;65(4):515\u2009\u2212\u200920. doi: 10.4088\/jcp.v65n0410.","DOI":"10.4088\/JCP.v65n0410"},{"key":"1644_CR84","doi-asserted-by":"crossref","unstructured":"84. Roscoe JA, Morrow GR, Hickok JT, Mustian KM, Griggs JJ, Matteson SE, et al. Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat. 2005;89(3):243-9. doi: 10.1007\/s10549-004-2175-1.","DOI":"10.1007\/s10549-004-2175-1"},{"key":"1644_CR85","doi-asserted-by":"crossref","unstructured":"85. Park HY, Lee BJ, Kim JH, Bae JN, Hahm BJ. Rapid improvement of depression and quality of life with escitalopram treatment in outpatients with breast cancer: a 12-week, open-label prospective trial. Prog Neuropsychopharmacol Biol Psychiatry. 2012;36(2):318\u2009\u2212\u200923. doi: 10.1016\/j.pnpbp.2011.11.010.","DOI":"10.1016\/j.pnpbp.2011.11.010"},{"key":"1644_CR86","doi-asserted-by":"crossref","unstructured":"86. Mathias C, Cardeal Mendes CM, Pond\u00e9 de Sena E, Dias de Moraes E, Bastos C, Braghiroli MI, et al. An open-label, fixed-dose study of bupropion effect on sexual function scores in women treated for breast cancer. Ann Oncol. 2006;17(12):1792-6. doi: 10.1093\/annonc\/mdl304.","DOI":"10.1093\/annonc\/mdl304"},{"key":"1644_CR87","doi-asserted-by":"crossref","unstructured":"87. Sanjida S, Janda M, Kissane D, Shaw J, Pearson SA, DiSipio T, et al. A systematic review and meta-analysis of prescribing practices of antidepressants in cancer patients. Psychooncology. 2016;25(9):1002-16. doi: 10.1002\/pon.4048.","DOI":"10.1002\/pon.4048"},{"issue":"10","key":"1644_CR88","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1093\/annonc\/mdn353","volume":"19","author":"M Hickey","year":"2008","unstructured":"Hickey M, Saunders C, Partridge A, Santoro N, Joffe H, Stearns V. Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer. Ann Oncol. 2008;19(10):1669\u201380. https:\/\/doi.org\/10.1093\/annonc\/mdn353.","journal-title":"Ann Oncol"},{"key":"1644_CR89","doi-asserted-by":"crossref","unstructured":"89. Loprinzi CL, Kugler JW, Sloan JA, Mailliard JA, LaVasseur BI, Barton DL, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet. 2000;356(9247):2059-63. doi: 10.1016\/s0140-6736(00)03403-6.","DOI":"10.1016\/S0140-6736(00)03403-6"},{"key":"1644_CR90","doi-asserted-by":"crossref","unstructured":"90. Boekhout AH, Vincent AD, Dalesio OB, van den Bosch J, Foekema-T\u00f6ns JH, Adriaansz S, et al. Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial. J Clin Oncol. 2011;29(29):3862-8. doi: 10.1200\/jco.2010.33.1298.","DOI":"10.1200\/JCO.2010.33.1298"},{"key":"1644_CR91","doi-asserted-by":"crossref","unstructured":"91. Leon-Ferre RA, Majithia N, Loprinzi CL. Management of hot flashes in women with breast cancer receiving ovarian function suppression. Cancer Treat Rev. 2017;52:82\u201390. doi: 10.1016\/j.ctrv.2016.11.012.","DOI":"10.1016\/j.ctrv.2016.11.012"},{"key":"1644_CR92","doi-asserted-by":"crossref","unstructured":"92. Henry NL, Unger JM, Schott AF, Fehrenbacher L, Flynn PJ, Prow DM, et al. Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202. J Clin Oncol. 2018;36(4):326\u2009\u2212\u200932. doi: 10.1200\/jco.2017.74.6651.","DOI":"10.1200\/JCO.2017.74.6651"},{"key":"1644_CR93","doi-asserted-by":"crossref","unstructured":"93. Wang J, Li Q, Xu B, Zhang T, Chen S, Luo Y. Efficacy and safety of duloxetine in Chinese breast cancer patients with paclitaxel-induced peripheral neuropathy. Chin J Cancer Res. 2017;29(5):411-8. doi: 10.21147\/j.issn.1000-9604.2017.05.05.","DOI":"10.21147\/j.issn.1000-9604.2017.05.05"},{"key":"1644_CR94","doi-asserted-by":"crossref","unstructured":"94. Kumar N, Barai S, Gambhir S, Rastogi N. Effect of Mirtazapine on Gastric Emptying in Patients with Cancer-associated Anorexia. Indian J Palliat Care. 2017;23(3):335-7. doi: 10.4103\/ijpc.Ijpc_17_17.","DOI":"10.4103\/IJPC.IJPC_17_17"},{"key":"1644_CR95","doi-asserted-by":"crossref","unstructured":"95. Desta Z, Ward BA, Soukhova NV, Flockhart DA. Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6. J Pharmacol Exp Ther. 2004;310(3):1062-75. doi: 10.1124\/jpet.104.065607.","DOI":"10.1124\/jpet.104.065607"},{"key":"1644_CR96","doi-asserted-by":"crossref","unstructured":"96. Jin Y, Desta Z, Stearns V, Ward B, Ho H, Lee KH, et al. CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. J Natl Cancer Inst. 2005;97(1):30\u2009\u2212\u20099. doi: 10.1093\/jnci\/dji005.","DOI":"10.1093\/jnci\/dji005"},{"key":"1644_CR97","doi-asserted-by":"crossref","unstructured":"97. Kelly CM, Juurlink DN, Gomes T, Duong-Hua M, Pritchard KI, Austin PC, et al. Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study. BMJ. 2010;340:c693. doi: 10.1136\/bmj.c693.","DOI":"10.1136\/bmj.c693"},{"key":"1644_CR98","doi-asserted-by":"crossref","unstructured":"98. Haque R, Shi J, Schottinger JE, Ahmed SA, Cheetham TC, Chung J, et al. Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16,887 Breast Cancer Survivors. J Natl Cancer Inst. 2016;108(3). doi: 10.1093\/jnci\/djv337.","DOI":"10.1093\/jnci\/djv337"},{"key":"1644_CR99","doi-asserted-by":"crossref","unstructured":"99. Bradbury M, Hutton B, Beltran-Bless A-A, Alzahrani M, Lariviere T, Fernandes R, et al. Time to Update Evidence-Based Guideline Recommendations About Concurrent Tamoxifen and Antidepressant Use? A Systematic Review. Clinical Breast Cancer. 2022;22(3):e362-e73. doi: 10.1016\/j.clbc.2021.10.003.","DOI":"10.1016\/j.clbc.2021.10.003"},{"key":"1644_CR100","doi-asserted-by":"publisher","unstructured":"100. Cardoso F, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rubio IT, et al. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020. Annals of Oncology. 2019;30(8):1194\u2009\u2212\u2009220. doi: https:\/\/doi.org\/10.1093\/annonc\/mdz173.","DOI":"10.1093\/annonc\/mdz173."},{"key":"1644_CR101","doi-asserted-by":"crossref","unstructured":"101. Gradishar WJ, Anderson BO, Abraham J, Aft R, Agnese D, Allison KH, et al. Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network J Natl Compr Canc Netw. 2020;18(4):452\u2009\u2212\u200978. doi: 10.6004\/jnccn.2020.0016.","DOI":"10.6004\/jnccn.2020.0016"},{"key":"1644_CR102","doi-asserted-by":"crossref","unstructured":"102. Vaidya R, Sood R, Karlin N, Jatoi A. Benzodiazepine use in breast cancer survivors: findings from a consecutive series of 1,000 patients. Oncology. 2011;81(1):9\u201311. doi: 10.1159\/000330814.","DOI":"10.1159\/000330814"},{"key":"1644_CR103","doi-asserted-by":"crossref","unstructured":"103. Sakamoto MR, Eguchi M, Azelby CM, Diamond JR, Fisher CM, Borges VF, et al. New Persistent Opioid and Benzodiazepine Use After Curative-Intent Treatment in Patients With Breast Cancer. J Natl Compr Canc Netw. 2021;19(1):29\u201338. doi: 10.6004\/jnccn.2020.7612.","DOI":"10.6004\/jnccn.2020.7612"},{"key":"1644_CR104","doi-asserted-by":"crossref","unstructured":"104. Syrowatka A, Chang SL, Tamblyn R, Mayo NE, Meguerditchian AN. Psychotropic and Opioid Medication Use in Older Patients With Breast Cancer Across the Care Trajectory: A Population-Based Cohort Study. J Natl Compr Canc Netw. 2016;14(11):1412-9. doi: 10.6004\/jnccn.2016.0151.","DOI":"10.6004\/jnccn.2016.0151"},{"key":"1644_CR105","doi-asserted-by":"crossref","unstructured":"105. Pandya KJ, Morrow GR, Roscoe JA, Zhao H, Hickok JT, Pajon E, et al. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet. 2005;366(9488):818\u2009\u2212\u200924. doi: 10.1016\/s0140-6736(05)67215-7.","DOI":"10.1016\/S0140-6736(05)67215-7"},{"key":"1644_CR106","doi-asserted-by":"crossref","unstructured":"106. Loprinzi CL, Qin R, Balcueva EP, Flynn KA, Rowland KM, Jr., Graham DL, et al. Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1. J Clin Oncol. 2010;28(4):641-7. doi: 10.1200\/jco.2009.24.5647.","DOI":"10.1200\/JCO.2009.24.5647"},{"key":"1644_CR107","doi-asserted-by":"crossref","unstructured":"107. Escalante CP, Meyers C, Reuben JM, Wang X, Qiao W, Manzullo E, et al. A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients. Cancer J. 2014;20(1):8\u201314. doi: 10.1097\/ppo.0000000000000018.","DOI":"10.1097\/PPO.0000000000000018"},{"key":"1644_CR108","doi-asserted-by":"crossref","unstructured":"108. Lower EE, Fleishman S, Cooper A, Zeldis J, Faleck H, Yu Z, et al. Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial. J Pain Symptom Manage. 2009;38(5):650\u2009\u2212\u200962. doi: 10.1016\/j.jpainsymman.2009.03.011.","DOI":"10.1016\/j.jpainsymman.2009.03.011"},{"key":"1644_CR109","doi-asserted-by":"crossref","unstructured":"109. Bower JE, Lacchetti C, Alici Y, Barton DL, Bruner D, Canin BE, et al. Management of Fatigue in Adult Survivors of Cancer: ASCO-Society for Integrative Oncology Guideline Update. J Clin Oncol. 2024;42(20):2456-87. doi: 10.1200\/jco.24.00541.","DOI":"10.1200\/JCO.24.00541"}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-025-01644-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11920-025-01644-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-025-01644-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:46:54Z","timestamp":1762418814000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11920-025-01644-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":109,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1644"],"URL":"https:\/\/doi.org\/10.1007\/s11920-025-01644-2","relation":{},"ISSN":["1535-1645"],"issn-type":[{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"1 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}